Targeted Next Generation Sequencing reveals previously unidentified and mutations
B M C Medical Genetics , Volume 16 - Issue 1
Background: Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in and . Conventional DNA diagnostic screens identify a or mutation in 75 - 90% of individuals categorised with definite TSC. The remaining individuals either have a mutation that is undetectable using conventional methods, or possibly a mutation in another as yet unidentified gene. Methods: Here we apply a targeted Next Generation Sequencing (NGS) approach to screen the complete and genomic loci in 7 individuals fulfilling the clinical diagnostic criteria for definite TSC in whom no or mutations were identified using conventional screening methods. Results: We identified and confirmed pathogenic mutations in 3 individuals. In the remaining individuals we identified variants of uncertain clinical significance. The identified variants included mosaic changes, changes located deep in intronic sequences and changes affecting promoter regions that would not have been identified using exon-only based analyses. Conclusions: Targeted NGS of the and loci is a suitable method to increase the yield of mutations identified in the TSC patient population.
|HaloPlex, Next Generation Sequencing, TSC1, TSC2, Tuberous sclerosis complex|
|B M C Medical Genetics|
|Organisation||Erasmus Center for Biomics|
Nellist, M.D, Brouwer, R.W.W, Kockx, C, van Veghel-Plandsoen, M, Withagen-Hermans, C.J, Prins-Bakker, L, … van IJcken, W.F.J. (2015). Targeted Next Generation Sequencing reveals previously unidentified and mutations. B M C Medical Genetics, 16(1). doi:10.1186/s12881-015-0155-4